Verve Therapeutics Ratios and Metrics

Market cap in millions AUD. Fiscal year is January - December.

Millions AUD. Fiscal year is Jan - Dec.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2022	FY 2021	2017 - 2020
Period Ending	Aug '25 Aug 1, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Jun '22 Jun 30, 2022	Jun '21 Jun 30, 2021	2017 - 2020
Market Capitalization	29	33	24	36	29	94	Upgrade
Market Cap Growth	-19.82%	37.07%	-33.47%	23.44%	-68.89%	152.94%	Upgrade
Enterprise Value	19	30	18	33	18	82	Upgrade
Last Close Price	0.04	0.04	0.05	0.12	0.14	0.45	Upgrade
PB Ratio	0.49	0.54	0.48	0.75	0.73	2.21	Upgrade
P/TBV Ratio	0.49	0.54	0.48	0.75	0.73	2.21	Upgrade
Debt / Equity Ratio	0.00	0.00	0.00	0.00	-	-	Upgrade
Asset Turnover	0.04	-	-	-	-	-	Upgrade
Quick Ratio	3.35	4.08	5.42	10.74	2.05	3.92	Upgrade
Current Ratio	3.61	4.24	5.73	11.14	2.18	3.94	Upgrade
Return on Equity (ROE)	-7.66%	-8.49%	-14.82%	-	-13.71%	-16.26%	Upgrade
Return on Assets (ROA)	-1.40%	-3.90%	-4.22%	-	-6.16%	-8.19%	Upgrade
Return on Capital (ROIC)	-1.72%	-4.72%	-4.96%	-	-7.34%	-9.32%	Upgrade
Earnings Yield	-13.81%	-14.31%	-30.54%	-11.34%	-19.39%	-5.20%	Upgrade
FCF Yield	-45.99%	-28.72%	-33.52%	-25.03%	-71.02%	-12.12%	Upgrade
Buyback Yield / Dilution	6.84%	-8.25%	-106.84%	-15.39%	-27.18%	-59.20%	Upgrade

Updated Oct 30, 2024. Source: S&P Global Market Intelligence. Standard template. Financial Sources.